Endocrinology, Vol 125, 2967-2972, Copyright © 1989 by Endocrine Society

ARTICLES

Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF-binding proteins in serum

DR Clemmons, JP Thissen, M Maes, JM Ketelslegers and LE Underwood
Department of Medicine, University of North Carolina, Chapel Hill 27599.

The insulin-like growth factors (IGFs) are small peptides that are present in serum and extracellular fluids and stimulate the growth of many cell types. In extracellular fluids the IGFs are bound to carrier proteins that are believed to modify the biological actions of the IGFs. At least three structurally distinct IGF-binding proteins (IGF- BPs) have been identified, and the serum concentrations of one of these has been shown to be regulated by pituitary GH. We report here that this GH responsive protein [39,000-45,000 mol wt (Mr)] can be induced (7-fold) by infusion of IGF-I in hypophysectomized rats or (3.5-fold) in protein-deprived rats, whereas two other forms of IGF-BP (e.g. 31,000-34,000 and 24,000 Mr) showed no change in the hypophysectomized animals and minimal increases in the protein-deprived animals. Likewise, GH injections in hypophysectomized animals resulted in a 7- fold increase in the 39,000-45,000 Mr form and no change in the 31,000- 34,000 and 24,000 Mr forms. The protein-deprived animals showed a 3.2- fold increase in the 39,000-45,000 Mr and 2.4- to 1.8-fold increases in the 31,000-34,000 and 24,000 Mr forms, respectively. Changes in the larger Mr IGF-BP in these experimental models are paralleled by changes in serum IGF-I, suggesting that the GH dependence of the former protein is mediated at least partially via IGF-I. Our findings also suggest that the secretion of IGF-I and at least one IGF-BP may be linked, providing a mechanism by which their extracellular fluid concentrations are coordinated. Because IGF-BPs are present in extracellular fluids and can modulate IGF-I-receptor interaction, induction of this protein may be an important mediator of IGF action.

This article has been cited by other articles:

				C. M. McHugh, R. T. Park, P. H. Sonksen, and R. I.G. Holt Challenges in Detecting the Abuse of Growth Hormone in Sport Clin. Chem., September 1, 2005; 51(9): 1587 - 1593. [Abstract] [Full Text] [PDF]

				S.-E. Kong, R. C. Baxter, and P. J. D. Delhanty Age-Dependent Regulation of the Acid-Labile Subunit in Response to Fasting-Refeeding in Rats Endocrinology, December 1, 2002; 143(12): 4505 - 4512. [Abstract] [Full Text] [PDF]

				T. PRIEGO, I. I. DE CACERES, A. I. MARTIN, M. A. VILLANUA, and A. LOPEZ-CALDERON Hepatic Insulin-like Growth Factor-I Binding Protein 3 Gene Expression in Rats with Endotoxic Shock: The Role of Glucocorticoids Ann. N.Y. Acad. Sci., November 1, 2002; 973(1): 88 - 90. [Abstract] [Full Text] [PDF]

				E. C. Crowne, J. S. Samra, T. Cheetham, C. L. Acerini, A. Watts, J. M. P. Holly, and D. B. Dunger The Role of IGF-Binding Proteins in Mediating the Effects of Recombinant Human IGF-I on Insulin Requirements in Type 1 Diabetes Mellitus J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3686 - 3691. [Abstract] [Full Text] [PDF]

				I. M. Holdaway, A. E. Lethaby, B. H. Mason, V. Singh, J. E. Harman, M. MacCormick, and I. D. Civil Effect of Breast Surgery on Serum Levels of Insulin-Like Growth Factors (IGF-I, IGF-II, and IGF Binding Protein-3) in Women With Benign and Malignant Breast Lesions Ann. Surg. Oncol., January 1, 2001; 8(1): 25 - 31. [Abstract] [Full Text] [PDF]

				L. Fernandez-Celemin and J.-P. Thissen Interleukin-6 Stimulates Hepatic Insulin-Like Growth Factor Binding Protein-4 Messenger Ribonucleic Acid and Protein Endocrinology, January 1, 2001; 142(1): 241 - 248. [Abstract] [Full Text] [PDF]

				F. Frick, J. Oscarsson, K. Vikman-Adolfsson, M. Ottosson, N. Yoshida, and S. Eden Different effects of IGF-I on insulin-stimulated glucose uptake in adipose tissue and skeletal muscle Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E729 - E737. [Abstract] [Full Text] [PDF]

				J. Frystyk, P. J. D. Delhanty, C. Skjarbak, and R. C. Baxter Changes in the circulating IGF system during short-term fasting and refeeding in rats Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E245 - E252. [Abstract] [Full Text] [PDF]

				C.-H. Fang, B.-G. Li, J. J. Wang, J. E. Fischer, and P.-O. Hasselgren Treatment of burned rats with insulin-like growth factor I inhibits the catabolic response in skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1091 - R1098. [Abstract] [Full Text] [PDF]

				J.A. Clapper, J.L. Snyder, A.J. Roberts, D.L. Hamernik, and G.E. Moss Estradiol Increases Relative Amounts of Insulin-Like Growth Factor Binding Protein (IGFBP)-3 in Serum and Expression of IGFBP-2 in Anterior Pituitaries of Ewes Biol Reprod, July 1, 1998; 59(1): 124 - 130. [Abstract] [Full Text]

				K. Berneis, R. Ninnis, J. Girard, B. M. Frey, and U. Keller Effects of Insulin-Like Growth Factor I Combined with Growth Hormone on Glucocorticoid-Induced Whole-Body Protein Catabolism in Man J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2528 - 2534. [Abstract] [Full Text] [PDF]

				A. F. Tarantal, M. K. Hunter, and S. E. Gargosky Direct Administration of Insulin-Like Growth Factor to Fetal Rhesus Monkeys (Macaca mulatta) Endocrinology, August 1, 1997; 138(8): 3349 - 3358. [Abstract] [Full Text] [PDF]

				R. V. Bhat, T. M. Engber, Y. Zhu, M. S. Miller, and P. C. Contreras Identification of Insulin-Like Growth Factor Binding Protein-2 as a Biochemical Surrogate Marker for the in Vivo Effects of Recombinant Human Insulin-Like Growth Factor-1 in Mice J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 522 - 530. [Abstract] [Full Text]

				Z. S. Gucev, Y. Oh, K. M. Kelley, J. I. Labarta, P. Vorwerk, and R. G. Rosenfeld Evidence for Insulin-Like Growth Factor (IGF)-Independent Transcriptional Regulation of IGF Binding Protein-3 by Growth Hormone in SKHEP-1 Human Hepatocarcinoma Cells Endocrinology, April 1, 1997; 138(4): 1464 - 1470. [Abstract] [Full Text] [PDF]